PerkinElmer (PKI) Misses Q4 EPS by 1c; Guides FY16 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Mizuho Securities Maintains Buy as PerkinElmer (PKI) Provides Positive Commentary on China Post 4Q
February 5, 2016 8:12 AM ESTMizuho Securities maintained a Buy rating on PerkinElmer (NYSE: PKI), and cut the price target to $52.00 (from $58.00), following the company's 4Q earnings report. PKI missed consensus estimates by $9mm and $0.01. Management had positive commentary on PKIs blood screening business in China. Mizuho... More
